Furthermore, a Kaplan–Meier analysis showed that elevated expression levels of RRM2 were correlated with diminished survival in HCC patients exhibiting varying degrees of differentiation (Figure 1D), alongside reduced progression-free survival (PFS), recurrence-free survival (RFS), and overall survival (OS) (Figure 1E). The gene discussed is RRM2; the disease is hepatocellular carcinoma.